Non-response to MTX was associated with ATIC rs3821353 in its codominant G/T model, as well as with SLC19A1 rs7279445 in its dominant forms’ C/T and C/C, indicating their bad prognostic significance for MTX treatment in RA patients. This evidence concerns the gene SLC19A1 and rheumatoid arthritis.